URSODEOXYCHOLIC ACID FOR THE PREVENTION OF SYMPTOMATIC GALLSTONE DISEASE AFTER BARIATRIC SURGERY: A MULTICENTRE, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED SUPERIORITY TRIAL

Sylke Haal  ¹     Maimoena S.S. Guman  ¹     Thomas C.C. Boerlage  ²     Yair I.Z. Acherman  ³     L. Maurits de Brauw  ³     Sjoerd Bruin  ³     Steve M.M. de Castro  ⁴     Jeanin van Hooft  ⁵     Arnold W.J.M. van de Laar  ⁵     Daan E. Moes  ⁶     Manon Schouten  ⁷     Ruben Schouten  ⁷     Ellert J. van Soest  ⁷     Ruben N. van Veen  ⁷     Claire E.E. de Vries  ⁷     Paul Fockens  ⁷     Marcel G.W. Dijkgraaf  ⁷     Victor E.A. Gerdes  ⁷     Rogier P. Voermans  ^7    
1 Amsterdam UMC, Locatie AMC/University of Amsterdam, Amsterdam, Netherlands
² UMCU, Utrecht, Netherlands
³ Spaarne Gasthuis, Hoofddorp, Netherlands
⁴ OLVG, Amsterdam, Netherlands
⁵ Leiden University Medical Center, Leiden, Netherlands
⁶ Dijklander Ziekenhuis, Hoorn, Netherlands
⁷ Flevoziekenhuis, Almere, Netherlands

Topic
Hepatobiliary

Session
Prevention and management of bile stone disease

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)